You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Globe+Newswire/Lexeo+Therapeutics+Receives+FDA+Regenerative+Medicine+Advanced+Therapy+%28RMAT%29+Designation+for+LX2020+for+the+Treatment+of+PKP2+Arrhythmogenic+Cardiomyopathy/26869980.html